Cisplatin Injection 50mg

Product Overview

Fortune Healthcare manufactures Cisplatin Injection, a platinum-based cytotoxic chemotherapy medicine, for treating advanced cancers of the bladder, ovaries, and testicles. Oncologists typically prescribe it as part of a combination chemotherapy regimen. It works by interfering with the DNA of rapidly dividing cancer cells, which stops them from growing and multiplying.

We supply this product as a 50mg/100ml solution in a single-use vial, meant solely for intravenous infusion in a hospital or specialist oncology setting. Trained healthcare professionals must directly supervise its use. Importantly, this medicine is not intended for self-administration, outpatient home use, or supply to individual patients without institutional or clinical oversight.

Precautions & Warnings

• For hospital/specialist use only — pharmacies should never dispense this for self-administration or outpatient home use
• Doctors should avoid prescribing it to patients with pre-existing severe kidney impairment, hearing impairment (unless clinically justified), or known hypersensitivity to platinum-containing compounds
• Ototoxicity: it may cause hearing loss or tinnitus, which can become irreversible; therefore, clinicians should monitor hearing throughout treatment
• Myelosuppression: the drug can significantly reduce blood cell counts, which raises infection and bleeding risk; as a result, clinicians must monitor blood counts closely
• Pregnancy and breastfeeding: since Cisplatin can cause fetal harm, doctors should advise effective contraception for patients of reproductive potential
• Handling precautions: because this is a cytotoxic agent, only trained personnel using proper protective equipment should handle it; additionally, pregnant healthcare workers should avoid contact with this product
• Drug interactions: combining this with other nephrotoxic or ototoxic drugs (e.g., aminoglycosides) increases risk, so the treating physician should review all concurrent medications
• Extravasation risk: clinicians must take care during IV administration, since leakage into surrounding tissue can damage local tissue

Overdose / Toxicity Management

Since trained clinical staff administer Cisplatin exclusively, “overdose” here refers to accidental clinical overdosing during preparation or administration rather than patient self-dosing. Signs may include severe myelosuppression, worsening kidney function, profound nausea or vomiting, hearing loss, or seizures.

No specific antidote exists for Cisplatin overdose. Instead, an oncologist or specialist team must direct supportive management, which may include stopping treatment, providing aggressive hydration, monitoring renal and hematologic parameters, and following institutional protocol for supportive care. If staff suspect an overdose, they should treat it as a medical emergency and escalate it to senior clinical staff immediately.

Storage Instructions

• Store the vial at 20–25°C (68–77°F) — never refrigerate it, since this can cause the solution to precipitate
• Protect the unopened container from light
• Never freeze it
• Keep it in original packaging until ready for clinical use
• Store and dispose of it according to institutional cytotoxic/hazardous drug handling protocols
• Keep it out of reach of unauthorized personnel

Why Choose Fortune Healthcare’s Cisplatin Injection

• Quality-assured manufacturing: we produce it under GMP-compliant conditions for institutional and hospital supply
• Reliable oncology portfolio: additionally, it’s part of our broader anti-cancer medicines range, alongside products like Etoposide, Paclitaxel, Pemetrexed, and Oxaliplatin injections
• Institutional supply capability: as a result, it suits hospital procurement, tender supply, and distributor partnerships
• Export experience: finally, we supply it to international markets with documentation support for regulatory submissions
  

  Frequently Asked Questions